E-Sirius Study: a European, Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms E-SIRIUS
- Sponsors Cordis Corporation
- 12 May 2009 Actual patient number (353) added as reported by ClinicalTrials.gov.
- 22 Oct 2008 Status changed from active, no longer recruiting to completed, according to clinicaltrials.gov.
- 01 Sep 2007 Results have been reported.